Medical Economics June 27, 2022
Richard Payerchin

AHRQ director says agency wants physician input on grappling with access, costs, burnout.

Robert Otto Valdez, PhD, MHSA, was appointed director of the federal Agency for Healthcare Research and Quality (AHRQ) in February 2022. Previously he served in a number of government and academic posts, including stints at the federal Department of Health and Human Services and as special senior adviser to the White House Initiative on Educational Excellence for Hispanic Americans. Nearing the end of the first full quarter in his tenure, Valdez spoke with Medical Economics to discuss the status of the American health care system and AHRQ’s role in finding solutions to current difficulties. The interview was conducted via Zoom and the following transcript has been edited...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Employer, Govt Agencies, Healthcare System, Insurance, Interview / Q&A, Patient / Consumer, Provider, Trends
Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread
AHRQ guide provides ways to support equity through digital health care technology
Healthcare prices surge 14% in last 5 years: Report
Bird Flu (H5N1) Explained: Here’s What To Know—And Why Scientists Are Concerned
A.C.C.E.S.S. AI: A New Framework For Advancing Health Equity In Health Care AI

Share This Article